EP2709613A2
Methods for treating hcv
96 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47 Sheet 48 Sheet 49 Sheet 50 Sheet 51 Sheet 52 Sheet 53 Sheet 54 Sheet 55 Sheet 56 Sheet 57 Sheet 58 Sheet 59 Sheet 60 Sheet 61 Sheet 62 Sheet 63 Sheet 64 Sheet 65 Sheet 66 Sheet 67 Sheet 68 Sheet 69 Sheet 70 Sheet 71 Sheet 72 Sheet 73 Sheet 74 Sheet 75 Sheet 76 Sheet 77 Sheet 78 Sheet 79 Sheet 80 Sheet 81 Sheet 82 Sheet 83 Sheet 84 Sheet 85 Sheet 86 Sheet 87 Sheet 88 Sheet 89 Sheet 90 Sheet 91 Sheet 92 Sheet 93 Sheet 94 Sheet 95 Sheet 96
141 members in 44 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 201161535885P | United States of America | – | |
| 201161535885 | United States of America | P | |
| 201161561753P | United States of America | – | |
| 201161561753 | United States of America | P | |
| 2012055621 | United States of America | W |
Members141
| Document | Office | Kind | |
|---|---|---|---|
| AP2014007575A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| CA2840242A1 | Canada | A1 | |
| WO2013040492A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2013109647A1 | United States of America | A1 | |
| CA2853495A1 | Canada | A1 | |
| WO2013066748A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201318627A | Taiwan Province of China | A | |
| US2013136776A1 | United States of America | A1 | |
| UY34420A | Uruguay | A | |
| CA2856529A1 | Canada | A1 | |
| WO2013082003A1 | World Intellectual Property Organization (WIPO) | A1 | |
| UY34474A | Uruguay | A | |
| TW201325599A | Taiwan Province of China | A | |
| WO2013040492A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2013243726A1 | United States of America | A1 | |
| EP2709613A2This record | European Patent Office (EPO) | A2 | |
| AU2012308295A1 | Australia | A1 | |
| CO6930366A2 | Colombia | A2 | |
| SG11201400664WA | Singapore | A | |
| IL231515A0 | Israel | A0 | |
| IL231515D0 | Israel | D0 | |
| MX2014003145A | Mexico | A | |
| AU2012332827A1 | Australia | A1 | |
| PH12014500557A1 | Philippines | A1 | |
| CO6970603A2 | Colombia | A2 | |
| AR088580A1 | Argentina | A1 | |
| AU2012346217A1 | Australia | A1 | |
| SG11201402609RA | Singapore | A | |
| AP2014007699A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| ECSP14013312A | Ecuador | A | |
| MX2014006373A | Mexico | A | |
| IL232889A0 | Israel | A0 | |
| IL232889D0 | Israel | D0 | |
| KR20140096029A | Republic of Korea | A | |
| CR20140177A | Costa Rica | A | |
| MD20140035A2 | Republic of Moldova | A2 | |
| PH12014501133A1 | Philippines | A1 | |
| PH12014501133B1 | Philippines | B1 | |
| AR089578A1 | Argentina | A1 | |
| PE20141056A1 | Peru | A1 | |
| CN104039319A | China | A | |
| KR20140108645A | Republic of Korea | A | |
| EP2776024A1 | European Patent Office (EPO) | A1 | |
| JP2014526516A | Japan | A | |
| EP2785340A1 | European Patent Office (EPO) | A1 | |
| PE20141296A1 | Peru | A1 | |
| CL2014001397A1 | Chile | A1 | |
| CR20140273A | Costa Rica | A | |
| DE202012013074U1 | Germany | U1 | |
| CL2014000630A1 | Chile | A1 | |
| US8889159B2 | United States of America | B2 | |
| EA201490903A1 | Eurasian Patent Organization (EAPO) | A1 | |
| MD20140058A2 | Republic of Moldova | A2 | |
| JP2014532657A | Japan | A | |
| JP2014533733A | Japan | A | |
| CN104244945A | China | A | |
| CN104244947A | China | A | |
| EA201490588A1 | Eurasian Patent Organization (EAPO) | A1 | |
| MA20150030A1 | Morocco | A1 | |
| DE202012013074U8 | Germany | U8 | |
| US2015150896A1 | United States of America | A1 | |
| HK1202268A | Hong Kong, China | A | |
| HK1202268A1 | Hong Kong, China | A1 | |
| KR101560994B1 | Republic of Korea | B1 | |
| ECSP14005678A | Ecuador | A | |
| MX336580B | Mexico | B | |
| AU2012346217B2 | Australia | B2 | |
| JP5899327B2 | Japan | B2 | |
| JP2016053096A | Japan | A | |
| SG10201602044WA | Singapore | A | |
| BR112014006324A2 | Brazil | A2 | |
| US9393256B2 | United States of America | B2 | |
| NZ623396A | New Zealand | A | |
| NZ625532A | New Zealand | A | |
| IL232889A | Israel | A | |
| DE202012013382U1 | Germany | U1 | |
| CN104244945B | China | B | |
| MD4430B1 | Republic of Moldova | B1 | |
| ZA201404061B | South Africa | B | |
| CN106166160A | China | A | |
| US2016354425A1 | United States of America | A1 | |
| TWI566773B | Taiwan Province of China | B | |
| US9549941B2 | United States of America | B2 | |
| JP6073897B2 | Japan | B2 | |
| JP2017057230A | Japan | A | |
| MD4430C1 | Republic of Moldova | C1 | |
| BR112014010295A2 | Brazil | A2 | |
| UA114097C2 | Ukraine | C2 | |
| IL231515A | Israel | A | |
| EA026667B1 | Eurasian Patent Organization (EAPO) | B1 | |
| BR112014012739A2 | Brazil | A2 | |
| BR112014012739A8 | Brazil | A8 | |
| US2017189439A1 | United States of America | A1 | |
| EA026667B9 | Eurasian Patent Organization (EAPO) | B9 | |
| EA027296B1 | Eurasian Patent Organization (EAPO) | B1 | |
| JP6220994B2 | Japan | B2 | |
| AU2012308295B2 | Australia | B2 | |
| NZ720391A | New Zealand | A | |
| EP2709613B1 | European Patent Office (EPO) | B1 | |
| US2017348342A1 | United States of America | A1 |
Showing 100 of 141
114 legal events, as 19 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11 | U11 | CH | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Publication of translation of european patent specificationUEP | UEP | AT | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Opt-out of the competence of the unified patent court (upc) changedP02 | P02 | EP | |
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Patent modifiedDC2A | DC2A | ES | |
| Translation of an amended european patent specificationT5 | T5 | SK | |
| Ep patent validated in greeceEP | EP | GR | |
| Amendment of european patent (b2) valid in norwayTB2 | TB2 | NO | |
| Amendment in the specificationLD4A | LD4A | EE | |
| Publication of translation of european patent specificationUEP | UEP | AT | |
| Translation of an amended ep patent after oppositionOppositionT4IZ | T4IZ | HR | |
| Ep patent has been republished in amended form after opposition at epoOppositionRPEO | RPEO | SE | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| Amended ep patent with danish claimsT4 | T4 | DK | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Patent maintained in amended form27A | 27A | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Epo decision maintaining patent in amended form now finalR102 | R102 | DE | |
| Maintained in amend formAELC | AELC | CH | |
| Patent maintained in amended formORIGINAL CODE: 0009272PUAH | PUAH | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA | STAA | EP | |
| Change of the address of the representativeNEW ADDRESS: WANNERSTRASSE 9/1, 8045 ZUERICH (CH)PCAR | PCAR | CH | |
| Renewal fee for the maintenance of a patentODRP | ODRP | HR | |
| Reply of patent proprietor to notice(s) of opposition receivedOppositionORIGINAL CODE: EPIDOSNOBS3PLBB | PLBB | EP | |
| Opposition filed (corrected)OppositionR26 | R26 | EP | |
| Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB | PLAB | EP | |
| Opposition filedOpposition26 | 26 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Notice of opposition and request to file observation + time limit sentOppositionORIGINAL CODE: EPIDOSNOBS2PLAX | PLAX | EP | |
| Opposition filedOppositionORIGINAL CODE: 0009260PLBI | PLBI | EP | |
| Opposition filed against patentOppositionR026 | R026 | DE | |
| Filing of the translation of the text of european patentsAG4A | AG4A | HU | |
| Standard patents granted in hong kongGrantedGR | GR | HK | |
| Ep patent validated in greeceEP | EP | GR | |
| Translation of european patent specification into slovakT3 | T3 | SK | |
| Entry of ep patent into national phase of norway [publ. of translation]T2 | T2 | NO | |
| Translation of the specification of european patent valid in estoniaFG4A | FG4A | EE | |
| Definitive protectionFG2A | FG2A | ES | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Ep patent validated in croatiaT1PR | T1PR | HR | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A | SC4A | PT | |
| Ep patent valid in romaniaEPE | EPE | RO | |
| Request for ep validation receivedTUEP | TUEP | HR | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| New agentNV | NV | CH | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP |
Showing 100 of 114
Numbers
- Publication
- 2709613
- Application
- 127689677
Titles3
- German
- VERFAHREN ZUR BEHANDLUNG VON HCV
- English
- METHODS FOR TREATING HCV
- French
- PROCÉDÉS PERMETTANT DE TRAITER LE VIRUS DE L'HÉPATITE C (HCV)
Classification
- CPC, 19
- A61K31/7072
- A61K31/381
- A61K31/4196
- A61K31/4184
- A61K31/513
- A61K45/06
- A61K31/7056
- A61K9/20
- A61K38/06
- A61K38/212
- A61P1/16
- A61P31/00
- A61P31/12
- A61P31/14
- A61P31/22
- A61P43/00
- A61K2300/00
- A61K9/0053
- A61K31/7052
- IPC, 5
- A61K31 381
- A61K31 4184
- A61K31 4196
- A61K31 513
- A61P31 14
Designated states2
- Contracting states, 1
- Türkiye
- Extension states, 1
- Montenegro
